Company: APXIF
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065703
Chunk: 198

Company: APx Acquisition Corp. I
Filing Date: 2025-07-18
Form: F-4/A
Chunk 198
---
, such securities may continue to be quoted on an over -the -countermarket. However, if this were to occur, our investors would likely face significant and material adverse consequences with respect to their investment in us, including, but not limited: •a limited availability of market quotations for our securities; •reduced liquidity for our securities; •as discussed above, a determination that our ordinary shares are “penny stock”, which will require brokers trading in such ordinary shares to adhere to more stringent rules and which likely would serve as an additional factor that may reduce the trading activity in the secondary trading market for our securities; •a limited amount of news and analyst coverage with respect to our securities; and •a decreased ability to issue additional securities or obtain additional financing in the future, which may adversely impact our efforts to consummate a Business Combination and otherwise continue its operations. As a result, an investor would likely find it more difficult to trade, or to obtain accurate price quotations for, our securities following our delisting from Nasdaq. Delisting would likely also reduce the visibility, liquidity and value of our securities, including as a result of reduced institutional investor interest in us, and may increase the volatility of our securities. Delisting could also cause a loss of confidence of potential business combination partners, which could further harm our ability to consummate a business combination. Additionally, following our delisting from Nasdaq, because we will no longer be required to comply with Nasdaq’s continued listing standards, our investors will not enjoy the protections afforded to investors by listed companies’ compliance with such standards. An additional potential negative consequence of delisting from the Nasdaq is that such delisting would likely lead to our securities losing their status as “covered securities.” The National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to as “covered securities.” While we currently satisfy the net tangible asset test exempting our securities as “covered securities”, there can be no assurance that we will satisfy such requirement in the future. Additionally, while 78 we expect the Company Shares and Company Warrants to be listed on Nasdaq, and therefore considered covered securities under such statute, there can be no assurance that the Company’s application to list the Company Shares and Company Warrants will be accepted, or that the Company will be able to maintain the listing of the Company Shares or Company Warrants. Although states are preempted from regulating the sale of our securities, this federal statute